Living with and after prostate cancer
National Cancer Survivorship Initiative. Self management support
for cancer survivors, Guidance for developing interventions March
2010 pg. 25
The Prostate Cancer Charity. Living with prostate cancer - online
snapshot survey, Feb 2009
Tiredness (fatigue)
Barsevick AM, Whitmer K, Sweeney C, Nail LM. A pilot study
examining energy conservation for cancer treatment-related fatigue.
Cancer Nurs. 2002 Oct;25(5):333-41.
Hervouet S, Savard J, Simard S, Ivers H, Laverdie`re J, Vigneault E
Fradet Y,
Lacombe L. Psychological functioning associated with prostate
cancer: cross-sectional comparison of patients treated with
radiotherapy, brachytherapy, or surgery. J Pain Symptom Management
2005; 30: 474-484.
Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders
in cancer patients: their nature, associations, and relation to
quality of life. J Clin Oncol. 2002 Jul 15; 20(14):3137-48
Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fosså SD. Fatigue in
hormone-naive prostate cancer patients treated with radical
prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic
Dis. 2010 Jun; 13(2):144-50.
Lilleby W, Fossa S, Waehre H, Olsen DR. Long-term morbidity and
quality of life in patients with localized prostate cancer
undergoing definitive radiotherapy or radical prostatectomy. Int J
Radiat Oncol Biol Phys 1998; 43: 735-743.
Maliski SL, Kwan L, Orecklin JR, Saigal CS, Litwin MS. Predictors
of fatigue after treatment for prostate cancer. Urology 2005; 65:
101-108.
National Comprehensive Cancer Network. NCCN Clinical Practice
Guidelines in Oncology, Cancer Related Fatigue v.1.2010
Segal R, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG,
Venner PM, Quinney HA, Jones LW, D'Angelo MES, Wells GA. Resistance
exercise in men receiving androgen deprivation therapy for prostate
cancer. J Clin Oncol. 2003. 21:1653-9.
Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG,
Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME. Randomized
controlled trial of resistance or aerobic exercise in men receiving
radiation therapy for prostate cancer. J Clin Oncol. 2009 Jan 20;
27(3):344-51.
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the androgen
deprivation syndrome in men receiving androgen deprivation for
prostate cancer. Archives of internal medicine 2006; 166(4):
465-71.
Stone P, Hardy J, Huddart R A'Hern R, Richards M.. Fatigue in
patients with prostate cancer receiving hormone therapy. European
journal of cancer 2000; 36(9): 1134-41.
Urinary problems
Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA,
Penson DF, Harlan LC. Five-year outcomes after prostatectomy or
radiotherapy for prostate cancer: the prostate cancer outcomes
study Journal of the National Cancer Institute 2004; 96:18
Shelley M, Wilt TJ, Coles B, Mason MD. Cryotherapy for localised
prostate cancer. Cochrane Database of Systematic Reviews 2007;
Issue 3
Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley
JW, Albertsen PC, Harlan LC, Potosky AL. 5-year urinary and sexual
outcomes after radical prostatectomy: results from the prostate
cancer outcomes study. J Urol 2005; 173: 1701-1705
Bowel problems
Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM
et al. Phase III pilot study of dose escalation using conformal
radiotherapy in prostate cancer: PSA control and side effects,
British Journal of Cancer. 2005; 92:488-498.
Kaptur G, Windsor PM and Mc Cowan C. The effect of aerobic exercise
on treatment-related acute toxicity in men receiving radical
external beam radiotherapy for localised prostate cancer. European
Journal of Cancer Care. 2009.
Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, Apte
AA, Deasy JO. Normal Tissue Complication Probability (NTCP)
modelling of late rectal bleeding following external beam
radiotherapy for prostate cancer: A Test of the QUANTEC-recommended
NTCP model. Oncol. 2010 Oct; 49(7):1040-4.
National Institute for Health and Clinical Excellence. Prostate
cancer. Diagnosis and treatment. NICE clinical guideline 58.
2008
Pinkawa M, Piroth MD, Fischedick K, Nussen S, Klotz J, Holy R, Eble
MJ. Self-assessed bowel toxicity after external beam radiotherapy
for prostate cancer - predictive factors on irrigative symptoms,
incontinence and rectal bleeding. Radiation Oncology. 2009;
4:36.
Sexual problems
Brotto LA, Morga Y, Breckon E. Psychological interventions for the
sexual sequelae of cancer: A review of the literature. J Cancer
Surviv 03 July 2010
Dalkin BL, Christopher BA. Preservation of penile length after
radical prostatectomy: early intervention with a vacuum erection
device. International Journal of Impotence Research 2007; 19
(5):501-4
Dorey G, Speakman MJ, Feneley RC, Swinkels A, Dunn CD. Pelvic floor
exercises for erectile dysfunction BJU International 2005; 96; 595
- 597
Hannan JL, Maio MT, Komolova M, Adams MA. Beneficial impact of
exercise and obesity interventions on erectile function and its
risk factors. Journal of Sexual Medicine 2009; 6 Suppl 3;
254-61
Human Fertilisation and Embryology Authority, code of practise. 8th
Edition 2009. Available at www.hfea.gov.uk
Molton IR, Siegel SD, Penedo FJ, Dahn JR, Kinsinger D, Traeger LN,
Carver CS, Shen BJ, Kumar M, Schneiderman N, Antoni MH. Promoting
recovery of sexual functioning after radical prostatectomy with
group-based stress management: The role of interpersonal
sensitivity. J Psychosom Res. 2008 May;64(5):527-36.
Nicolosi A, Laumann E O, Glasser D B, Moreira E D, Paik A,
Gingell C. Sexual behaviour and sexual dysfunctions after the age
40: the global study of sexual attitudes and behaviours. Urology
2004; 64: 991-997
Northouse LL. Mood DW. Schafenacker A. Montie
JE. Sandler HM. Forman JD. Hussain M.
Pienta KJ. Smith DC. Kershaw T Randomized clinical
trial of a family intervention for prostate cancer patients and
their spouses. Cancer. 110(12):2809-18, 2007 Dec
15.
Penedo FJ, Traeger L, Dahn J, Molton I, Gonzalez JS, Schneiderman
N, Antoni MH. Cognitive behavioural stress management intervention
improves quality of life in Spanish monolingual Hispanic men
treated for localized prostate cancer: Results of a randomized
controlled trial International Journal of Behavioural
Medicine Volume 14, Number 3, 164-172
Tengs T O, Osgood N D. The link between smoking and impotence: two
decades of evidence. Preventative Medicine 2001; 32 (6):
447-52
Living with hormone therapy
Autorino R, Perdonà S, D'Armiento M, De Sio M, Damiano R, Cosentino
L, Di Lorenzo G. Gynecomastia in patients with prostate cancer:
update on treatment options.Prostate Cancer Prostatic Dis.
2006;9(2):109-14.
Eastham JA. Bone health in men receiving androgen deprivation
therapy for prostate cancer. J Urol 2007; 177:17-24
European Association of Urology. Guidelines on prostate cancer.
2010
Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The
effect of androgen deprivation therapy on body composition in men
with prostate cancer: systematic review and meta-analysis. J Cancer
Surviv 2010 Jun; 4(2):128-39.
Kim HS, Moreira DM, Smith MR, Presti JC Jr, Aronson WJ, Terris MK,
Kane CJ, Amling CL, Freedland SJ. A natural history of weight
change in men with prostate cancer on androgen-deprivation therapy
(ADT): results from the Shared Equal Access Regional Cancer
Hospital (SEARCH) database. BJU Int. 2011 Mar;
107(6):924-928.
McLeod DG. Tolerability of nonsteroidal antiandrogens in the
treatment of advanced prostate cancer. Oncologist 1997; 2:
18-27.
Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of
hormone therapy in men with prostate cancer: a review. Cancer 2008;
113:1097-106.
Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton
AS, Gilliland FD, Eley JW, Stephenson RA, Hoffman RM.
Quality-of-Life outcomes after primary androgen deprivation
therapy: results from the prostate cancer outcomes study. J Clin
Oncol 2009; 19(17):3750-3757.
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the androgen
deprivation syndrome in men receiving androgen deprivation for
prostate cancer. Archives of internal medicine 2006; 166(4):
465-71.
Stone P, Hardy J, Huddart R A'Hern R, Richards M.. Fatigue in
patients with prostate cancer receiving hormone therapy. European
journal of cancer 2000; 36(9): 1134-41.
Pain
European Urology Association. Guidelines on pain management..
2010.
Royal College of Physicians. Principles of pain control in
palliative care for adults. [Consensus statement on the Internet].
London: Royal College of Physicians. 2000
World Health Organisation. Cancer pain relief: with a Guide to
Opioid Availability, 2nd ed. Geneva: WHO 1996.
Risk of other health problems
Alibhai SMH, Gogov S, Alllibhai Z. Long-term side effects of
androgen deprivation therapy in men with non-metastatic prostate
cancer: a systematic literature review. Critical reviews in
Oncology/Haematology 60 (2006) 201-215
Department of Health and Human Services (HHS), Department of
Agriculture (USDA). Dietary Guidelines for Americans, 2010.
Washington, DC: US Government Printing Office; 2005.
Drudge-Coates L. Bone health: the effect of androgen deprivation
therapy in prostate cancer patients. International Journal of
Urological Nursing 2007; 1(1): 18-26.
Eastham JA. Bone health in men receiving androgen deprivation
therapy for prostate cancer. J Urol 2007; 177:17-24
Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Cardiovascular
and metabolic complications during androgen deprivation: exercise
as a potential countermeasure. Prostate Cancer Prostatic Dis. 2009;
12(3):233-40.
Gomella LG. Contemporary use of hormonal therapy in prostate
cancer: managing complications and addressing quality-of-life
issues. BJU International 2007; 99 Supp.1: 25-29.
Hakimian P, Blute M Jr, Kashanian J, Chan S, Silver D, Shabsigh R.
Metabolic and cardiovascular effects of androgen deprivation
therapy BJU 2008; 102:1509-14.
Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith
MR, Sternberg CN, Studer UE Androgen deprivation therapy for
the treatment of prostate cancer: consider both benefits and risks.
Eur Urol. 2009 Jan; 55(1):62-75.
Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle
recommendations revision 2006: a scientific statement from the
American Heart Association Nutrition Committee. Circulation 2006;
114:82-96
National Osteoporosis Society. Osteoporosis: causes, prevention and
treatment. 2001. Bath: NOS.
Smith MR, Boyce SP, Moyneur E, Duh MS, Raut MK, Brandman J. Risk of
clinical fractures after gonadotropin-releasing hormone agonist
therapy for prostate cancer. J Urol. 2006 Jan; 175(1):136-9;
discussion 139.
Diet and physical activity
Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ,
Giovannucci EL. Diet after diagnosis and the risk of prostate
cancer progression, recurrence, and death (United States). Cancer
Causes Control. 2006; 17(2):199-208.
Department of Health. Start Active, Stay Active. A report on
physical activity for health from the four home countries' Chief
Medical Officers (2011) Available at: http://www.bhfactive.org.uk/homepage-latest-news-item/75/index.html
Food Standards Agency: http://www.eatwell.gov.uk/healthydiet/eighttipssection/8tips/
Accessed 10 August 2010.
Ma RW-L, Chapman K. A systematic review of the effect of diet in
prostate cancer prevention and treatment. Journal of Human
Nutrition and Dietetics. 2009; 22:187-99.
Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D,
Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Physical activity in
relation to total, advanced, and fatal prostate cancer. Cancer
Epidemiol Biomarkers Prev. 2008; 17(9):2458-66.
Segal R, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG,
Venner PM, Quinney HA, Jones LW, D'Angelo MES, Wells GA. Resistance
exercise in men receiving androgen deprivation therapy for prostate
cancer. J Clin Oncol. 2003. 21:1653-9.
Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review
of physical activity in prostate cancer survivors: outcomes,
prevalence, and determinants. Support Care Cancer. 2008;
16:987-997.
Van Patten CL, de Boer JG & Tomlinson Guns ES. Diet and dietary
supplement intervention trials for the prevention of prostate
cancer recurrence: A review of the randomized controlled trial
evidence. The Journal of Urology. 2008; 180:2314-2
World Cancer Research Fund/American Institute for Cancer. Food,
Nutrition, Physical Activity and the Prevention of Cancer: A Global
Perspective. Washington DC: AICR, 2007
Prostate cancer and your feelings
Bailey D, Mishel M, Belyea M, Stewart J, Mholer, Clark J (2004)
Uncertainty intervention for watchful waiting in prostate cancer.
Cancer Nurs 27: 339-346
Beard C, Stason WB, Wang Q, Manola J, Dean-Clower E, Dusek JA,
Decristofaro S, Webster A, Rosenthal DS, Benson H. Effects of
complementary therapies on clinical outcomes in patients being
treated with radiation therapy for prostate cancer. Cancer. 2010
Aug 27.
Ben-Tovim DI, Dougherty ML, Stapleton AM, Pinnock CB Coping with
prostate cancer: a quantitative analysis using a new instrument,
the centre for clinical excellence in urological research coping
with cancer instrument. Urology. 2002 Mar; 59(3):383-8.
Bottomley, A., Where are we now? Evaluating two decades of group
interventions with adult cancer patients. J Psychiatr Ment Health
Nurs, 1997. 4(4): p. 251-65.
Carlson LE, Bultz BD. Mind-body interventions in oncology. Curr
Treat Options Oncol. 2008 Jun;9(2-3):127-34.
Couper, JW, Bloch S, Love A, Duchesne G, Macvean M and Kissane DW.
The psychosocial impact of prostate cancer on patients and their
partners. Medical Journal of Australia, 185(8) 428-432
Foley E, Baillie A, Huxter M, Price M, Sinclair E.
Mindfulness-based cognitive therapy for individuals whose lives
have been affected by cancer: a randomized controlled trial. J
Consult Clin Psychol. 2010 Feb;78(1):72-9.
Helgason AR., Dickman PW, Adolfsson J et al. Emotional Isolation:
Prevalence and the Effect on Wellbeing Among 50-80-Year-Old
Prostate Cancer Patients, Scand J Urol Nephrol 35: 97-101,
2001
Khan NF, Ward AM, Watson E, Rose PW. Consulting and prescribing
behaviour for anxiety and depression in long-term survivors of
cancer in the UK. Eur J Cancer. 2010 Aug 18
Navon L, Morag A. Advanced prostate cancer patients' relationships
with their spouses following hormonal therapy. Eur J Oncol Nurs.
2003 Jun; 7(2):73-80; discussion 81-2.
Nelson C, Jacobson CM, Weinberger MI, Bhaskaran V, Rosenfeld B,
Breitbart W, Roth AJ. The role of spirituality in the relationship
between religiosity and depression in prostate cancer patients.
Annals of Behavioural Medicine 38(2): 105-14, 2009 Oct
Oliffe J. Embodied masculinity and androgen deprivation therapy.
Sociology of Health and Illness 2006; 28(4): 410-432.
Parahoo K, McCaughan E, Noyes J, McDonough S. The effectiveness of
psychosocial interventions for men with prostate cancer: a
systematic review. Intervention Protocal. Cochrane Database of
Systematic Reviews. 2010, Issue ^. Art No.: CD008529
Pirl WF, Siegel GI, Goode MJ, Smith MR. Depression in men receiving
androgen deprivation therapy for prostate Cancer: a pilot study.
Psychooncology 2002;11:518-23.
Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M.
Antidepressants for depression in physically ill people. Cochrane
Database of Systematic Reviews 2010, Issue 3. Art. No.: CD007503.
DOI: 10.1002/14651858.CD007503.pub2
Ream E, Quennel A, Fincham L, Faithfull S, Knoo V, Wilson-Barnett
J, Richardson A. Supportive care needs of men living with prostate
cancer in England: a survey. Br J Cancer. 2008 Jun 17;
98(12):1903-9.
Seidman SN, Spatz E, Rizzo C, Roose SP. Testosterone replacement
therapy for hypogonadal men with major depressive disorder: a
randomized, placebo-controlled clinical trial. J Clin Psychiatry
2001; 62:406-12.
Seidman SN, Walsh BT. Testosterone deficiency and depression in
aging men. Am J Geriatric Psychiatry 1999; 7:18-33.
Seidman SN. Testosterone and depression in aging men: Pathogenic
and therapeutic implications. J Gend Specif Med 2001; 4:44-8.
Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review
of physical activity in prostate cancer survivors: outcomes,
prevalence, and determinants.
Support Care Cancer. 2008; 16:987-997.
Wallace M. Uncertainty and quality of life of older men who
undergo watchful waiting for prostate cancer. Oncology Nursing
Forum 2003; 30, 303-309.
Weber BA, Sherwill-Navarro P. Psychosocial consequences of prostate
cancer: 30 years of research. Geriatric Nursing 2005; 26:166-75
Relationships
Couper J, Bloch S, Love A, Duchesne G, Macvean M, Kissane D. Coping
patterns and psychosocial distress in female partners of prostate
cancer patients. Psychosomatics. 50(4):375-82, 2009 Jul-Aug
Giesler RB, Given B, Given CW, Rawl S, Monahan P, Burns D, Azzouz
F, Reuille KM, Weinrich S, Koch M, Champion V. Improving the
quality of life of patients with prostate carcinoma: a randomized
trial testing the efficacy of a nurse-driven intervention. Cancer.
2005 Aug 15;104(4):752-62.
Harden J, Northouse L, Mood, D. Qualitative analysis of couples'
experience with prostate cancer by age cohort. Cancer Nursing, vol
29. No 5, 2006
Manne S, Badr H. Zaider T. Nelson C. Kissane D. Cancer related
communication, relationship intimacy, and psychological distress
among couples with localised prostate cancer. Journal of Cancer
Survivorship. 4(1):74-85, 2010 March
Northouse LL. Mood DW. Schafenacker A. Montie
JE. Sandler HM. Forman JD. Hussain M.
Pienta KJ. Smith DC. Kershaw T. Cancer.
Randomized clinical trial of a family intervention for prostate
cancer patients and their spouses. 110(12):2809-18, 2007 Dec
15.
Partners and family members
Boehmer U, Clark JA: Communication about prostate cancer
between men and their wives. J of Fam Pract 2001, 50:226-231.
Cliff A, Macdonagh R. Psychosocial morbidity in prostate cancer:
ll. A comparison of patients and partners. BJU International.
2000;86:834-9.
Eton DT, Lepore SJ. Prostate cancer and health-related quality of
life: a review of the literature. Psycho-Oncol. 2002;
11(4):307)
Evertsen JM Wolkenstein A S. Female partners of patients after
surgical prostate cancer treatment: interactions with physicians
and support needs. BMC Family Practice 2010, 11:19
Garos S. Kluck A. Aronoff D. Prostate cancer patients
and their partners: differences in satisfaction indices and
psychological variables. Journal of Sexual Medicine.
4(5):1394-403, 2007 Sep.
Harden J, Schafenacker A, Northouse L, Mood D, Smith D, et al:
Couples' experiences with prostate cancer: focus group research.
Oncol Nurs Forum 2002, 29(4):701-709.
Kornblith AB, Herr HW. Quality of life of patients with prostate
cancer and their spouses. Cancer. 1994; 73:2791-802.5.
Lavery JF, Clarke VA: Prostate cancer: patients' and spouses'
coping and marital adjustment. Psychol Health Med 1999,
4(3):289-302.
Manne S, Badr H, Zaider T, Nelson C, Kissane D. Cancer-related
communication, relationship intimacy, and psychological distress
among couples coping with localised prostate cancer. J Cancer
Surviv (2010) 4:74-85
Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, et al:
Living with prostate cancer: patients' and spouses' psychosocial
status and quality of life. J Clin Oncol 2007, 25:4171-4177.
Sinfield, P. Meeting the needs of carers of men with prostate
cancer. Research grant award, final report (2009)
Daily life and prostate cancer
de Boer AG, Verbeek JH, Spelten ER, Uitterhoeve AL, Ansink AC, de
Reijke TM, Kammeijer M, Sprangers MA, van Dijk FJ. Work ability and
return-to-work in cancer patients. British Journal of Cancer
(2008), 98, 1342-1347
Grunfield EA, Rixon L, Eaton E, Cooper AF. The organisational
perspective on the return to work of employees following treatment
for cancer. J Occup Rehabil. 2008 Dec; 18(4):381-8
The Prostate Cancer Charity. Living with prostate cancer - online
snapshot survey, Feb 2009